Journal
CURRENT VASCULAR PHARMACOLOGY
Volume 9, Issue 2, Pages 153-157Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/157016111794519345
Keywords
EPC; angiotensin II; ARB; oxidative stress; PPAR gamma
Funding
- Ministry of Education, Science, Sports, and Culture
- Takeda Science Foundation
Ask authors/readers for more resources
Angiotensin II regulates blood pressure and contributes to endothelial dysfunction and the progression of atherosclerosis. Bone marrow-derived endothelial progenitor cells (EPCs) in peripheral blood contribute to postnatal vessel repair and neovascularization. Impaired EPC function in patients with hypertension and diabetes inhibits the endogenous repair of vascular lesions and leads to the progression of atherosclerosis. The number of EPCs in peripheral blood is inversely correlated with mortality and the occurrence of cardiovascular events. Angiotensin II-mediated signaling is implicated in oxidative stress, inflammation and insulin resistance, factors that cause EPC dysfunction. Blockade of the angiotensin II type 1 receptor may therefore present a new therapeutic target for enhancing EPC function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available